Bionano Genomics, Inc. (BNGO) stock
BNGONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 12/3083% below fair value
$0.95+0.01 (+1.29%)
Close on Nov 17, 2026Market cap $11.21MP/E –Yield –
Bionano Genomics gross margin
Gross margin is gross profit as a percentage of revenue.
Bionano Genomics's gross margin for the twelve months ending Jun 30, 2026 was 47.5%. For fiscal 2025 it was 46.3%, against 1.2% the year before. The highest annual figure on record is 46.3% in fiscal 2025.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 46.3% | +45.0 |
| FY2024 | Dec 31, 2024 | 1.2% | −25.3 |
| FY2023 | Dec 31, 2023 | 26.5% | +5.1 |
| FY2022 | Dec 31, 2022 | 21.4% | −0.2 |
| FY2021 | Dec 31, 2021 | 21.5% | −11.1 |
| FY2020 | Dec 31, 2020 | 32.6% | −0.6 |
| FY2019 | Dec 31, 2019 | 33.2% | +5.8 |
| FY2018 | Dec 31, 2018 | 27.4% | −9.1 |
| FY2017 | Dec 31, 2017 | 36.6% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 52.8% | +1.2 |
| Q1 FY2026 | Mar 31, 2026 | 48.6% | +3.1 |
| Q4 FY2025 | Dec 31, 2025 | 42.7% | +0.9 |
| Q3 FY2025 | Sep 30, 2025 | 45.7% | +184.8 |
| Q2 FY2025 | Jun 30, 2025 | 51.6% | +18.4 |
| Q1 FY2025 | Mar 31, 2025 | 45.5% | +13.3 |
| Q4 FY2024 | Dec 31, 2024 | 41.9% | +19.1 |
| Q3 FY2024 | Sep 30, 2024 | -139.1% | −168.6 |
| Q2 FY2024 | Jun 30, 2024 | 33.3% | +6.6 |
| Q1 FY2024 | Mar 31, 2024 | 32.2% | +4.3 |
| Q4 FY2023 | Dec 31, 2023 | 22.7% | +0.8 |
| Q3 FY2023 | Sep 30, 2023 | 29.5% | +4.5 |
| Q2 FY2023 | Jun 30, 2023 | 26.6% | +4.6 |
| Q1 FY2023 | Mar 31, 2023 | 27.9% | +12.8 |
| Q4 FY2022 | Dec 31, 2022 | 22.0% | +18.2 |
| Q3 FY2022 | Sep 30, 2022 | 25.1% | +0.3 |
| Q2 FY2022 | Jun 30, 2022 | 22.1% | −15.3 |
| Q1 FY2022 | Mar 31, 2022 | 15.1% | −17.8 |
| Q4 FY2021 | Dec 31, 2021 | 3.8% | −25.8 |
| Q3 FY2021 | Sep 30, 2021 | 24.8% | −8.7 |
| Q2 FY2021 | Jun 30, 2021 | 37.3% | −11.7 |
| Q1 FY2021 | Mar 31, 2021 | 32.9% | +8.3 |
| Q4 FY2020 | Dec 31, 2020 | 29.5% | −9.8 |
| Q3 FY2020 | Sep 30, 2020 | 33.5% | +5.2 |
| Q2 FY2020 | Jun 30, 2020 | 49.0% | +20.5 |
| Q1 FY2020 | Mar 31, 2020 | 24.6% | −13.5 |
| Q4 FY2019 | Dec 31, 2019 | 39.4% | +13.8 |
| Q3 FY2019 | Sep 30, 2019 | 28.3% | +36.8 |
| Q2 FY2019 | Jun 30, 2019 | 28.5% | −18.0 |
| Q1 FY2019 | Mar 31, 2019 | 38.1% | −14.3 |
| Q4 FY2018 | Dec 31, 2018 | 25.5% | −21.9 |
| Q3 FY2018 | Sep 30, 2018 | -8.5% | −46.9 |
| Q2 FY2018 | Jun 30, 2018 | 46.5% | +21.1 |
| Q1 FY2018 | Mar 31, 2018 | 52.4% | +22.5 |
| Q4 FY2017 | Dec 31, 2017 | 47.4% | – |
| Q3 FY2017 | Sep 30, 2017 | 38.4% | – |
| Q2 FY2017 | Jun 30, 2017 | 25.4% | – |
| Q1 FY2017 | Mar 31, 2017 | 30.0% | – |
See a number that looks wrong?